Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-014808
Filing Date
2023-03-02
Accepted
2023-03-02 17:02:24
Documents
1
Period of Report
2023-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6703
  Complete submission text file 0001209191-23-014808.txt   8187
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Issuer) CIK: 0001322505 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALBIREO PHARMA, INC. 53 STATE STREET, 19TH FLOOR BOSTON MA 02109
Business Address
Alesina Susan (Reporting) CIK: 0001941475 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33451 | Film No.: 23700120